INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$6.0M

$5,963,032

View Raw Line-Items
Live Feed: 2026-03-11
BIOA M
BioAge Labs, Inc.
RUBIN PAUL D • Officer • Chief Medical Officer
Other
2026-03-02 $35,470x2
BIOA S
BioAge Labs, Inc.
RUBIN PAUL D • Officer • Chief Medical Officer
10b5-1 Sell
2026-03-02 $150,890
BIOA M
BioAge Labs, Inc.
Other
2026-03-01 $15,514
BIOA M
BioAge Labs, Inc.
RUBIN PAUL D • Officer • Chief Medical Officer
Other
2026-02-02 $35,470x2
BIOA S
BioAge Labs, Inc.
RUBIN PAUL D • Officer • Chief Medical Officer
10b5-1 Sell
2026-02-02 $139,369
BIOA M
BioAge Labs, Inc.
Other
2026-02-01 $15,510
BIOA M
BioAge Labs, Inc.
Other
2026-01-16 $15,514
BIOA S
BioAge Labs, Inc.
Fortney Kristen • CEO
10b5-1 SellΔOwn -19.3%
2026-01-13 $4,223,036Large
BIOA M
BioAge Labs, Inc.
Other
2026-01-13 $226,530
BIOA S
BioAge Labs, Inc.
10b5-1 Sell
2026-01-13 $531,828x4
BIOA M
BioAge Labs, Inc.
RUBIN PAUL D • Officer • Chief Medical Officer
Equity Compensation
2025-12-09 $118,260x2
BIOA S
BioAge Labs, Inc.
RUBIN PAUL D • Officer • Chief Medical Officer
10b5-1 Sell
2025-12-09 $216,000
BIOA M
BioAge Labs, Inc.
RUBIN PAUL D • Officer • Chief Medical Officer
Equity Compensation
2025-12-04 $283,167x2
BIOA S
BioAge Labs, Inc.
RUBIN PAUL D • Officer • Chief Medical Officer
10b5-1 Sell
2025-12-04 $701,909